Rockwell Financial Statements From 2010 to 2024

RMTI Stock  USD 2.20  0.13  5.58%   
Rockwell Medical financial statements provide useful quarterly and yearly information to potential Rockwell Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Rockwell Medical financial statements helps investors assess Rockwell Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rockwell Medical's valuation are summarized below:
Rockwell Medical does not presently have any trending fundamental ratios for analysis.
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Rockwell Medical Company Return On Equity Analysis

Rockwell Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Rockwell Medical Return On Equity

    
  -0.29  
Most of Rockwell Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rockwell Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Rockwell Medical has a Return On Equity of -0.289. This is 98.79% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 6.77% lower than that of the firm.

Rockwell Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Rockwell Medical's current stock value. Our valuation model uses many indicators to compare Rockwell Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rockwell Medical competition to find correlations between indicators driving Rockwell Medical's intrinsic value. More Info.
Rockwell Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rockwell Medical's earnings, one of the primary drivers of an investment's value.

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people.

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.